ELIANA VILLADO: Open Payments
NPI 1316505175 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 16 payments from 9 companies in 2025. Trend: 2023 $601 · 2024 $79 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Veloxis Pharmaceuticals, Inc. | 2 | $71 |
| KYOWA KIRIN, INC. | 2 | $47 |
| Apellis Pharmaceuticals, Inc. | 2 | $35 |
| CorMedix Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: FARXIGA, ENVARSUS, CRYSVITA, Empaveli, DEFENCATH, JYNARQUE, ULTOMIRIS, JARDIANCE.
Industry payments across TX — which companies pay providers there.
